Editorial Commentary: Immunodeficiency at Start of Antiretroviral Therapy: The Persistent Problem of Late Presentation to Care

Similar Items

• Editorial Commentary: Comparative Efficacy of Lamivudine and Emtricitabine: Comparing the Results of Randomized Trials and Cohorts
  od: Ford, Nathan, i dr.
  Izdano: (2015)
• Editorial Commentary: Scaling Up Antiretroviral Preexposure Prophylaxis: Moving From Trials to Implementation
  od: Mayer, Kenneth H., i dr.
  Izdano: (2015)
• Authors’ response: Immunodeficiency at Start of Combination Antiretroviral Therapy 2002–2010: Steady Improvement
  od: Koller, Manuel, i dr.
  Izdano: (2015)
• Editorial Commentary: Can We Afford to Control the HIV Epidemic With Antiretrovirals? Can We Afford Not to Do So?
  od: Mayer, Kenneth H., i dr.
  Izdano: (2016)
• The Persistent Challenge of Advanced HIV Disease and AIDS in the Era of Antiretroviral Therapy
  od: Calmy, Alexandra, i dr.
  Izdano: (2018)